Abstract
Why is the organic industry growing faster in some countries than in others? Research shows that public funds are being developed for sufficient research for the robust biotech industry. What should countries and regions do to compete globally in this region? In this book, I focus on the top of biotechnology development – the creation of a new tech company – and take a closer look at Portugal, a country where the industry has long been at the fetal level. From this analysis, it will be clear to the general manager that the above to foster the development of common technologies may not be appropriate for managing a department with many unique characteristics. Evidence from a number of countries suggests that there is a decisive factor that needs to emerge for the biotech industry. A closer look at the Portuguese model, when combined with European and global biotech developments, could help regions such as Southeast Asia and Southern Europe define their approach to competition.
Introduction
Biological technologies are increasingly recognized as important for the economic growth of countries and regions, regardless of their level of development
[1]. The direct practices of biotechnology enable it to bring new forms of employment into a wide range of industries, including the medical and agricultural sectors, agriculture, environmental protection, and many other sectors. The emergence of biology as a major economic power among developed countries is now a global phenomenon [2-4]. In the United States, for example, the availability of private entrepreneurs and the commercial potential of scientists and engineers, as well as strong pressure from established companies – the pharmaceutical industry – have proven to be a major cause of biotechnology in some. it has become a great economic power, consuming about half a million people, directly or indirectly.2 On the other hand, precarious conditions have emerged. Let crop technology be scarce. development [5-10], a fact that has prompted many governments to take action to encourage the growth of this sector. As it does so, biological development in the region is now a daunting task, becoming increasingly important for local and local governments to better understand what needs to be done to make their biotech companies competitive.